Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.463
Delayed Data
As of 12:15pm ET
 -0.017 / -3.54%
Today’s Change
0.36
Today|||52-Week Range
3.66
+24.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$55.9M

Company Description

CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Contact Information

CytRx Corp.
11726 San Vicente Boulevard
Los Angeles California 90049
P:(310) 826-5648
Investor Relations:

Employees

Shareholders

Individual stakeholders7.22%
Mutual fund holders6.86%
Other institutional10.85%

Top Executives

Steven A. KriegsmanChairman, President & Chief Executive Officer
Daniel J. LevittChief Operating & Medical Officer
John Y. CalozChief Financial Officer & Treasurer
Douglas Scott WielandSenior Vice President-Drug Development
Shanta P. ChawlaVice President-Clinical Development